🇺🇸 FDA
Pipeline program

Ganciclovir

MV17973

Approved small_molecule completed

Quick answer

Ganciclovir for Cytomegalovirus Infections is a Approved program (small_molecule) at Hoffmann-La Roche with 1 ClinicalTrials.gov record(s).

Program details

Company
Hoffmann-La Roche
Indication
Cytomegalovirus Infections
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials